Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435546
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2023-11-27
Brief Title:
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
Sponsor:
Institut de Cancérologie de Lorraine
Organization:
Institut de Cancérologie de Lorraine
Study Overview
Official Title:
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers a Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AdOTAC
Brief Summary:
AdOTAC is a pilot study open prospective single-center one-arm The 200 patients will be included Patient is included at Day 0 The included patient will have the opportunity to complete the self-questionnaires either at the ICL on Day 0 or at home up to 10 days after the date of inclusion in the study Blood samples are collected the day of enrolment Day 0 in order to measure the following biological markers ferritin serum iron TSAT albumin and haemoglobin except if performed as part of routine care in the previous 6 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None